Basel, 25 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ: GNMK) at a price of $24.05 per share. The tender offer is being made pursuant to the previously announced merger... Read more
Thermo Fisher Scientific Completes FDA Listing and Launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing CARLSBAD, Calif., March 25, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug... Read more
New 3D/2D surgical imaging system, OEC 3D, brings precise 3D and 2D imaging to surgical suites improving efficiency Salt Lake City – March 23, 2021 – GE Healthcare today announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. OEC 3D will set a standard... Read more
Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution Collaboration agreement between Thermo Fisher Scientific and Artificial enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency TORONTO, March 23, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation... Read more
Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON–(BUSINESS WIRE)– Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D... Read more
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission Accurate detection and differentiation of SARS-CoV-2 mutations can help assess the spread of circulating variants and monitor their potential impact on therapeutics, vaccines and public health interventions Periodic assessments against emerging variants have... Read more
From scanning electron microscopy data to tactile teaching tools In 2017, Dr. Alex Ball, head of Imaging and Analysis at the Natural History Museum London (NHM), approached ZEISS with an intriguing idea. What if one could take 3D microscopy data sets and create tangible objects using 3D printers? This would create a physical teaching object... Read more
CHELMSFORD, Mass., March 15, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021 which includes a 35-minute webcast beginning at 1:15 p.m. ET. The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. ... Read more
Basel, 15 March 2021 Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the... Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization Mar 10, 2021 6:30 AM EST AUSTIN, Texas, March 10, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an... Read more